- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Lennox-Gastaut syndrome
- Meeting Date: September 2022
- Public Summary Document (PSD) September 2022 PBAC Meeting - (PDF 83KB)
- Public Summary Document (PSD) September 2022 PBAC Meeting - (Word 526KB)
Cannabidiol – September 2022
Cannabidiol: Oral liquid 100 mg per mL, 100 mL; Epidyolex® – September 2022
Last updated
23 December 2022